Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.76 USD | -6.40% | -23.54% | +20.66% |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
04-16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.66% | 11.88M | |
+19.05% | 47.02B | |
+48.77% | 41.86B | |
+0.29% | 41.76B | |
-4.27% | 28.8B | |
+11.59% | 26.05B | |
-21.99% | 19.15B | |
+4.20% | 12.55B | |
+29.25% | 12.34B | |
-4.38% | 11.82B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Therapeutics Plans 1-for-240 Reverse Stock Split